【4578】大塚ホールディングス
製薬。抗精神病。機能性食品『ポカリスエット』など。
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024.12 | 2024/10/31 | Q3予 | 2,310,000 | ↓ | -0.2% | +7.9% | 320,000 | ↑ | +6.0% | -3.0% | - | - | - | - | 240,000 | → | 0.0% | -4.0% |
2024.12 | 2024/08/01 | Q2予 | 2,315,000 | ↑ | +8.2% | +8.2% | 302,000 | ↓ | -8.5% | -8.5% | - | - | - | - | 240,000 | ↓ | -4.0% | -4.0% |
2024.12 | 2024/04/30 | Q1予 | 2,140,000 | → | 0.0% | 0.0% | 330,000 | → | 0.0% | 0.0% | - | - | - | - | 250,000 | → | 0.0% | 0.0% |
2024.12 | 2024/02/14 | 当初予 | 2,140,000 | - | - | - | 330,000 | - | - | - | - | - | - | - | 250,000 | - | - | - |
2023.12 | 2024/02/14 | 実 | 2,018,568 | ↑ | +0.0% | +12.1% | 139,612 | ↑ | +0.4% | -33.5% | - | - | - | - | 121,616 | ↑ | +0.5% | -22.8% |
2023.12 | 2024/02/13 | 修正予 | 2,018,000 | ↑ | +1.7% | +12.1% | 139,000 | ↓ | -43.3% | -33.8% | 142,000 | - | - | - | 121,000 | ↓ | -35.6% | -23.2% |
2023.12 | 2023/10/31 | Q3予 | 1,985,000 | ↑ | +4.2% | +10.3% | 245,000 | → | 0.0% | +16.7% | - | - | - | - | 188,000 | → | 0.0% | +19.4% |
2023.12 | 2023/07/31 | Q2予 | 1,905,000 | ↑ | +5.8% | +5.8% | 245,000 | ↑ | +16.7% | +16.7% | - | - | - | - | 188,000 | ↑ | +19.4% | +19.4% |
2023.12 | 2023/05/12 | Q1予 | 1,800,000 | → | 0.0% | 0.0% | 210,000 | → | 0.0% | 0.0% | - | - | - | - | 157,500 | → | 0.0% | 0.0% |
2023.12 | 2023/02/14 | 当初予 | 1,800,000 | - | - | - | 210,000 | - | - | - | - | - | - | - | 157,500 | - | - | - |
2022.12 | 2023/02/14 | 実 | 1,737,998 | ↑ | +1.6% | +12.1% | 150,323 | ↑ | +5.9% | -21.7% | - | - | - | - | 134,019 | ↑ | +2.3% | -8.2% |
2022.12 | 2022/10/31 | Q3予 | 1,710,000 | ↑ | +2.4% | +10.3% | 142,000 | ↓ | -6.6% | -26.0% | - | - | - | - | 131,000 | ↓ | -3.0% | -10.3% |
2022.12 | 2022/07/29 | Q2予 | 1,670,000 | ↑ | +7.7% | +7.7% | 152,000 | ↓ | -20.8% | -20.8% | - | - | - | - | 135,000 | ↓ | -7.5% | -7.5% |
2022.12 | 2022/02/10 | 当初予 | 1,550,000 | - | - | - | 192,000 | - | - | - | - | - | - | - | 146,000 | - | - | - |
2021.12 | 2022/02/10 | 実 | 1,498,276 | ↑ | +0.0% | +5.3% | 154,497 | ↓ | -5.2% | -19.5% | - | - | - | - | 125,463 | ↑ | +0.4% | -14.1% |
2021.12 | 2022/01/27 | 修正予 | 1,498,000 | ↑ | +1.2% | +5.3% | 163,000 | ↓ | -19.7% | -15.1% | 163,000 | - | - | - | 125,000 | ↓ | -22.4% | -14.4% |
2021.12 | 2021/11/12 | Q3予 | 1,480,000 | → | 0.0% | +4.0% | 203,000 | ↓ | -2.4% | +5.7% | - | - | - | - | 161,000 | ↓ | -2.4% | +10.3% |
2021.12 | 2021/08/06 | Q2予 | 1,480,000 | ↑ | +4.0% | +4.0% | 208,000 | ↑ | +8.3% | +8.3% | - | - | - | - | 165,000 | ↑ | +13.0% | +13.0% |
2021.12 | 2021/05/13 | Q1予 | 1,423,000 | → | 0.0% | 0.0% | 192,000 | → | 0.0% | 0.0% | - | - | - | - | 146,000 | → | 0.0% | 0.0% |
2021.12 | 2021/02/12 | 当初予 | 1,423,000 | - | - | - | 192,000 | - | - | - | - | - | - | - | 146,000 | - | - | - |
2020.12 | 2021/02/12 | 実 | 1,422,826 | ↑ | +0.2% | -1.5% | 198,582 | ↓ | -2.2% | +0.8% | - | - | - | - | 148,137 | ↓ | -1.2% | +2.2% |
2020.12 | 2020/11/13 | Q3予 | 1,420,000 | ↑ | +0.7% | -1.7% | 203,000 | ↑ | +0.5% | +3.0% | 195,000 | ↓ | -2.5% | 0.0% | 150,000 | → | 0.0% | +3.4% |
2020.12 | 2020/08/07 | Q2予 | 1,410,000 | ↓ | -2.4% | -2.4% | 202,000 | ↑ | +2.5% | +2.5% | 200,000 | ↑ | +2.6% | +2.6% | 150,000 | ↑ | +3.4% | +3.4% |
2020.12 | 2020/05/28 | Q1予 | 1,445,000 | → | 0.0% | 0.0% | 197,000 | → | 0.0% | 0.0% | 195,000 | → | 0.0% | 0.0% | 145,000 | → | 0.0% | 0.0% |
2020.12 | 2020/02/14 | 当初予 | 1,445,000 | - | - | - | 197,000 | - | - | - | 195,000 | - | - | - | 145,000 | - | - | - |
2019.12 | 2020/02/14 | 実 | 1,396,240 | ↓ | -0.3% | +0.4% | 176,585 | ↑ | +1.5% | +17.7% | 173,515 | ↑ | +2.1% | +17.6% | 127,151 | ↑ | +1.7% | +15.6% |
2019.12 | 2019/11/12 | Q3予 | 1,400,000 | → | 0.0% | +0.7% | 174,000 | → | 0.0% | +16.0% | 170,000 | → | 0.0% | +15.3% | 125,000 | → | 0.0% | +13.6% |
2019.12 | 2019/08/08 | Q2予 | 1,400,000 | ↑ | +0.7% | +0.7% | 174,000 | ↑ | +16.0% | +16.0% | 170,000 | ↑ | +15.3% | +15.3% | 125,000 | ↑ | +13.6% | +13.6% |
2019.12 | 2019/05/14 | Q1予 | 1,390,000 | → | 0.0% | 0.0% | 150,000 | → | 0.0% | 0.0% | 147,500 | → | 0.0% | 0.0% | 110,000 | → | 0.0% | 0.0% |
2019.12 | 2019/02/13 | 当初予 | 1,390,000 | - | - | - | 150,000 | - | - | - | 147,500 | - | - | - | 110,000 | - | - | - |
2018.12 | 2019/02/13 | 実 | 1,291,981 | ↑ | +0.2% | -0.6% | 108,304 | ↓ | -14.7% | -22.6% | 109,497 | ↓ | -14.5% | -20.1% | 82,492 | ↓ | -17.5% | -21.4% |
2018.12 | 2018/11/14 | Q3予 | 1,290,000 | ↓ | -0.8% | -0.8% | 127,000 | ↓ | -12.4% | -9.3% | 128,000 | ↓ | -12.9% | -6.6% | 100,000 | ↓ | -13.0% | -4.8% |
2018.12 | 2018/08/08 | Q2予 | 1,300,000 | → | 0.0% | 0.0% | 145,000 | ↑ | +3.6% | +3.6% | 147,000 | ↑ | +7.3% | +7.3% | 115,000 | ↑ | +9.5% | +9.5% |
2018.12 | 2018/05/11 | Q1予 | 1,300,000 | → | 0.0% | 0.0% | 140,000 | → | 0.0% | 0.0% | 137,000 | → | 0.0% | 0.0% | 105,000 | → | 0.0% | 0.0% |
2018.12 | 2018/02/14 | 当初予 | 1,300,000 | - | - | - | 140,000 | - | - | - | 137,000 | - | - | - | 105,000 | - | - | - |
2017.12 | 2018/02/14 | 実 | 1,239,952 | ↓ | 0.0% | -1.6% | 104,181 | ↑ | +0.2% | -13.2% | 103,712 | ↑ | +0.7% | -12.8% | 112,492 | ↑ | +0.4% | +32.3% |
2017.12 | 2018/02/08 | 修正予 | 1,240,000 | ↓ | -1.6% | -1.6% | 104,000 | ↓ | -13.3% | -13.3% | 103,000 | ↓ | -13.4% | -13.4% | 112,000 | ↑ | +31.8% | +31.8% |
2017.12 | 2017/11/14 | Q3予 | 1,260,000 | → | 0.0% | 0.0% | 120,000 | → | 0.0% | 0.0% | 119,000 | → | 0.0% | 0.0% | 85,000 | → | 0.0% | 0.0% |
2017.12 | 2017/08/08 | Q2予 | 1,260,000 | → | 0.0% | 0.0% | 120,000 | → | 0.0% | 0.0% | 119,000 | → | 0.0% | 0.0% | 85,000 | → | 0.0% | 0.0% |
2017.12 | 2017/05/12 | Q1予 | 1,260,000 | → | 0.0% | 0.0% | 120,000 | → | 0.0% | 0.0% | 119,000 | → | 0.0% | 0.0% | 85,000 | → | 0.0% | 0.0% |
2017.12 | 2017/02/14 | 当初予 | 1,260,000 | - | - | - | 120,000 | - | - | - | 119,000 | - | - | - | 85,000 | - | - | - |
2016.12 | 2017/02/14 | 実 | 1,195,547 | ↓ | -0.4% | -4.4% | 101,145 | ↓ | -12.0% | +44.5% | 116,680 | ↑ | +1.5% | +45.8% | 92,563 | ↑ | +8.9% | +85.1% |
2016.12 | 2016/11/11 | Q3予 | 1,200,000 | ↓ | -4.0% | -4.0% | 115,000 | ↑ | +64.3% | +64.3% | 115,000 | ↑ | +43.8% | +43.8% | 85,000 | ↑ | +70.0% | +70.0% |
2016.12 | 2016/05/13 | Q1予 | 1,250,000 | → | 0.0% | 0.0% | 70,000 | → | 0.0% | 0.0% | 80,000 | → | 0.0% | 0.0% | 50,000 | → | 0.0% | 0.0% |
2016.12 | 2016/02/12 | 当初予 | 1,250,000 | - | - | - | 70,000 | - | - | - | 80,000 | - | - | - | 50,000 | - | - | - |
2015.12 | 2016/02/12 | 実 | 1,445,227 | ↑ | +2.5% | +5.5% | 151,837 | ↑ | +4.7% | +38.0% | 159,899 | ↑ | +6.6% | +33.2% | 84,086 | ↓ | -6.6% | +5.1% |
2015.12 | 2015/11/13 | Q3予 | 1,410,000 | ↑ | +2.2% | +2.9% | 145,000 | ↑ | +20.8% | +31.8% | 150,000 | ↑ | +20.0% | +25.0% | 90,000 | ↑ | +12.5% | +12.5% |
2015.12 | 2015/08/07 | Q2予 | 1,380,000 | ↑ | +0.7% | +0.7% | 120,000 | ↑ | +9.1% | +9.1% | 125,000 | ↑ | +4.2% | +4.2% | 80,000 | → | 0.0% | 0.0% |
2015.12 | 2015/05/13 | Q1予 | 1,370,000 | → | 0.0% | 0.0% | 110,000 | → | 0.0% | 0.0% | 120,000 | → | 0.0% | 0.0% | 80,000 | → | 0.0% | 0.0% |
2015.12 | 2015/02/13 | 当初予 | 1,370,000 | - | - | - | 110,000 | - | - | - | 120,000 | - | - | - | 80,000 | - | - | - |
2014.12 | 2015/02/13 | 実 | 1,224,298 | ↑ | +2.0% | +2.0% | 196,528 | ↑ | +3.4% | +3.4% | 217,210 | ↑ | +11.4% | +11.4% | 143,143 | ↑ | +10.1% | +10.1% |
2014.12 | 2014/11/13 | Q2予 | 1,200,000 | → | 0.0% | 0.0% | 190,000 | → | 0.0% | 0.0% | 195,000 | → | 0.0% | 0.0% | 130,000 | → | 0.0% | 0.0% |
2014.12 | 2014/08/08 | Q1予 | 1,200,000 | → | 0.0% | 0.0% | 190,000 | → | 0.0% | 0.0% | 195,000 | → | 0.0% | 0.0% | 130,000 | → | 0.0% | 0.0% |
2014.12 | 2014/05/14 | 当初予 | 1,200,000 | - | - | - | 190,000 | - | - | - | 195,000 | - | - | - | 130,000 | - | - | - |
2014.03 | 2014/05/14 | 実 | 1,452,759 | - | - | - | 198,702 | - | - | - | 215,235 | - | - | - | 150,989 | - | - | - |